Other Events ·
On June 15, 2026, Azitra, Inc. filed a certificate of amendment to increase its authorized common stock from…
AZTRAzitra, Inc.
On June 15, 2026, Azitra, Inc. filed a certificate of amendment to increase its authorized common stock from 200,000,000 to 750,000,000 shares. Stockholders also approved the Board's authority to effect one or more reverse stock splits and authorized the issuance of more than 19.99% of outstanding shares related to securities purchase agreements with Alumni Capital LP and other investors. Stockholders rejected a proposal to amend and restate the 2023 Stock Incentive Plan to increase the authorized share reserve. The company operates in the biotechnology industry, focusing on the development of novel therapeutics and vaccines.